1. Home
  2. ALTI vs ESPR Comparison

ALTI vs ESPR Comparison

Compare ALTI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

N/A

Current Price

$4.78

Market Cap

394.0M

Sector

Finance

ML Signal

N/A

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

N/A

Current Price

$3.64

Market Cap

898.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALTI
ESPR
Founded
2020
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.0M
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ALTI
ESPR
Price
$4.78
$3.64
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$6.86
AVG Volume (30 Days)
165.2K
6.4M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$226,717,000.00
$303,802,000.00
Revenue This Year
$19.78
$25.45
Revenue Next Year
$7.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.83
52 Week Low
$2.33
$0.69
52 Week High
$5.45
$4.13

Technical Indicators

Market Signals
Indicator
ALTI
ESPR
Relative Strength Index (RSI) 60.69 53.96
Support Level $5.01 $3.72
Resistance Level $5.45 $4.13
Average True Range (ATR) 0.34 0.22
MACD 0.06 -0.04
Stochastic Oscillator 59.44 10.19

Price Performance

Historical Comparison
ALTI
ESPR

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: